Research and Clinical Trials
Search Cancer Clinical Trials
Clinical Trials
New Search
| Title | A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (Study No. V212-001 |
|---|---|
| Description | This is a study to determine whether investigational V212 reduces the incidence of herpes zoster (HZ) compared to placebo when administered to recipients of autologous hematopoietic cell transplants (HCT). |
| Eligibility Criteria | To be eligible for this study, patients must meet several criteria, including but not limited to the following: * Patient must be 18 Years and older * Subject has prior history of varicella, antibodies to VZV (documented prior to receipt of blood products), or residence in a country with endemic VZV infection for more than or equal to 30 years or if participant is less than 30 years old, attended primary or secondary school in a country with endemic VZV infection. * Subject is scheduled to undergo an autologous hematopoietic cell transplant within 60 days of enrollment |
| Principal Investigator | Ira Braunschweig, MD |
| Contact Name | Dale Wyville, PA |
| Phone | (718) 405-8547 |
| Contact Email | dwyville@montefiore.org |
| Post Date | 10/25/2010 |
| Protocol Number | 10-09-292/West |
| Status | Recruting |
| Current Trial Type | Interventional |
